title: 192 IgG-saporin lesion of basal forebrain cholinergic neurons in neonatal rats.
abstract: Seven day old rats received bilateral intraventricular injections (200 ng) of the immunotoxin 192 IgG-saporin. When assayed in adulthood, these rats showed an 84% loss of hippocampal and a 52% loss of cortical choline acetyltransferase (ChAT) activity. ChAT was unaffected in the caudate. Cholinergic neurons immunoreactive (IR) for the low affinity neurotrophin receptor (P75NTR) were severely reduced throughout the basal forebrain nuclei. Cortical and hippocampal norepinephrine were increased and these areas showed ingrowth of ectopic, P75NTR and dopamine beta-hydroxylase IR varicosities. These were probably sympathetic axons. No obvious forebrain dysmorphogenesis was observed and cortical thickness was unaffected. These rats showed no evidence of impaired spatial learning/memory as assessed by the Morris water maze and delayed spatial alternation. However, they were less active on the elevated plus apparatus and spent less time on the open arms, suggestive of increased timidity. 192 IgG-saporin appears to be a powerful tool to selectively lesion basal forebrain cholinergic neurons in the neonatal rat. Surprisingly, the neuromorphological and behavioral sequelae seem minimal. It may be necessary to achieve near-total neonatal destruction of forebrain cholinergic neurons before severe, lasting mnemonic effects are evident.
authors.affiliation: Institute of Neuroscience, Carleton University, Ottawa, Ont., Canada. bpappas@ccs.carleton.ca
authors.forename: B A
authors.initials: BA
authors.lastname: Pappas
authors.forename: C M
authors.initials: CM
authors.lastname: Davidson
authors.forename: T
authors.initials: T
authors.lastname: Fortin
authors.forename: S
authors.initials: S
authors.lastname: Nallathamby
authors.forename: G A
authors.initials: GA
authors.lastname: Park
authors.forename: E
authors.initials: E
authors.lastname: Mohr
authors.forename: R G
authors.initials: RG
authors.lastname: Wiley
mesh_terms: D000109:Acetylcholine / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D000911:Antibodies, Monoclonal / Q000633:toxicity*; D001369:Axons / Q000737:chemistry; D018678:Cholinergic Agents / Q000633:toxicity*; D005260:Female; D007150:Immunohistochemistry; D000922:Immunotoxins / Q000633:toxicity*; D007276:Injections, Intraventricular; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009699:N-Glycosyl Hydrolases; D009474:Neurons / Q000187:drug effects* / Q000648:ultrastructure; D016548:Prosencephalon / Q000166:cytology / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor / Q000032:analysis; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D013037:Spatial Behavior / Q000187:drug effects
chemical_list: C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor; D054789:Ribosome Inactivating Proteins, Type 1; D009699:N-Glycosyl Hydrolases; D000076985:Saporins; D000109:Acetylcholine